Facial rejuvenation with botulinum

Botulinum toxin type A (Botox) blocks the release of neurotransmitter acetylcholine at the presynaptic neuromuscular junction leading to an irreversible, but temporary muscular paralysis and weakness. This can produce a significant improvement of wrinkling in the upper face caused by the actions of the facial muscles. A prospective clinical study representing a 15-month experience with this new technique is presented. Patient selection and evaluation, classification of animation lines, techniques, results, and complications are discussed.